Cited by 53Computational Drug Discovery MethodsPhytochemicals and Medicinal PlantsSARS-CoV-2 and COVID-19 Research

Phytochemicals present in Indian ginseng possess potential to inhibit SARS-CoV-2 virulence: A molecular docking and MD simulation study

Open access
Kushwaha, Prem Prakash, Singh, Atul Kumar, Prajapati, Kumari Sunita, Shuaib, Mohd, Gupta, Sanjay, Kumar, Shashank·2021·Microbial Pathogenesis

Abstract

Coronaviruses are deadly and contagious pathogens that affects people in different ways. Researchers have increased their efforts in the development of antiviral agents against coronavirus targeting M pro protein (main protease) as an effective drug target. The present study explores the inhibitory potential of characteristic and non-characteristic Withania somnifera (Indian ginseng) phytochemicals (n ≈ 100) against SARS-Cov-2 M pro protein. Molecular docking studies revealed that certain W. somnifera compounds exhibit superior binding potential (-6.16 to -12.27 kcal/mol) compared to the standard inhibitors (-2.55 to -6.16 kcal/mol) including nelfinavir and lopinavir. The non-characteristic compounds (quercetin-3-rutinoside-7-glucoside, rutin and isochlorogenic acid B) exhibited higher inhibitory potential in comparison to characteristic W. somnifera compounds withanolide and withanone. Molecular dynamics (MD) simulation studies of the complex for 100 ns confirm favorable and stable binding of the lead molecule. The MMPBSA calculation of the last 10 ns of the protein-ligand complex trajectory exhibited stable binding of quercetin-3-rutinoside-7-glucoside at the active site of SARS-Cov-2 M pro. Taken together, the study demonstrates that the non-characteristic compounds present in W. somnifera possess enhanced potential to bind SARS-Cov-2 M pro active site. We further recommend in vitro and in vivo experimentation to validate the anti-SARS-CoV-2 potential of these lead molecules.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.micpath.2021.104954

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 2

  1. [18]Tiwari A. Kushwaha P.P. Kumar S. Future scope for Withania somnifera in anticancer drug discovery Proceedings of the 105th Indian Science Congress, Section of New Biology (Including Biochemistry, Biophysics & Molecular Biology and Biotechnology) at vol. 180 2018 Manipur University Imphal 3-7 January, 2018
  2. [35]Duke J.A. Database of Phytochemical Constituents of GRAS Herbs and Other Economic Plants 1992 CRC Press

Cited by

Sorted by citations

Authors
Kushwaha, P. P., Singh, A. K., Prajapati, K. S., Shuaib, M., Gupta, S., & Kumar, S.
Affiliations
  • Central University of Punjab (IN)
  • Case Western Reserve University (US)
Corresponding author
Kumar, Shashank
Venue
Microbial Pathogenesis
Publisher
Elsevier BV
Published
2021-08
Volume
157
Pages
104954
ISSN
0882-4010 (ISSN-L)
OpenAlex
W3164745116
Cited by
53
References
45
Citations by year
2026: 1 · 2025: 5 · 2024: 6 · 2023: 9 · 2022: 27 · 2021: 5
FWCI
6.17
Type
journal article
Language
en
Open access
Locations
  • Microbial Pathogenesis (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Computer Science › Computational Theory and Mathematics › Computational Drug Discovery Methods
  • Health Sciences › Medicine › Complementary and alternative medicine › Phytochemicals and Medicinal Plants
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Keywords
Withania somnifera, phytochemicals, SARS-CoV-2, main protease, antiviral agents, rutin, withanolides, withanone, protein-ligand binding, molecular docking, molecular dynamics simulation, MM-PBSA
MeSH terms
COVID-19, SARS-CoV-2, Antiviral Agents, Panax, Humans, Virulence, Molecular Dynamics Simulation, Molecular Docking Simulation, Phytochemicals

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review